NovaBridge Biosciences (NBP) Selling, General & Administrative (2019 - 2025)
NovaBridge Biosciences (NBP) Selling, General & Administrative (2019 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
SG&A (Qtr) |
| 1 |
Alterity Therapeutics |
767,934.24 Bn |
767,934.20 Bn |
- |
- |
| 2 |
Belite Bio |
55,234.00 Bn |
55,234.00 Bn |
- |
17.02 Mn |
| 3 |
Quantum Biopharma |
17,823.14 Bn |
17,823.14 Bn |
- |
1.32 Mn |
| 4 |
Legend Biotech |
3,624.50 Bn |
3,624.21 Bn |
242.10 Mn |
-37.00 Mn |
| 5 |
Akari Therapeutics |
1,745.73 Bn |
1,745.73 Bn |
- |
2.17 Mn |
| 6 |
Evaxion A |
1,540.85 Bn |
1,540.84 Bn |
- |
-1.52 Mn |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
217,225.00 |
| 8 |
Vertex Pharmaceuticals |
112.57 Bn |
105.33 Bn |
2.59 Bn |
493.70 Mn |
| 9 |
Abivax |
93.46 Bn |
93.46 Bn |
- |
-7.36 Mn |
| 10 |
NovaBridge Biosciences |
331.49 Mn |
120.65 Mn |
- |
45.49 Mn |
| Date | Value |
|---|
| Dec 31, 2025 |
45.49 Mn |
| Sep 30, 2025 |
-5.81 Mn |
| Jun 30, 2025 |
-3.82 Mn |
| Mar 31, 2025 |
-4.49 Mn |
| Dec 31, 2024 |
51.97 Mn |
| Sep 30, 2024 |
-7.94 Mn |
| Jun 30, 2024 |
-11.94 Mn |
| Mar 31, 2024 |
-2.44 Mn |
| Dec 31, 2023 |
48.06 Mn |
| Sep 30, 2023 |
-5.86 Mn |
| Jun 30, 2023 |
-7.92 Mn |
| Dec 31, 2020 |
-13.83 Mn |
| Sep 30, 2020 |
-44.88 Mn |
| Dec 31, 2019 |
175.55 Mn |
| Sep 30, 2019 |
-1.16 Mn |
